BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38057016)

  • 1. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.
    Yang U; Harikrishna A; Preda V; Chen J
    Clin Nutr ESPEN; 2023 Dec; 58():27-49. PubMed ID: 38057016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
    BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?
    Umlauff L; Weber M; Freitag N; Fairman CM; Heidenreich A; Bloch W; Schumann M
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):149-158. PubMed ID: 34193946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of resistance exercise on body composition and physical function in prostate cancer patients undergoing androgen deprivation therapy: an update systematic review and meta-analysis.
    Tian S; Ding M; Sun H
    Aging Male; 2022 Dec; 25(1):281-292. PubMed ID: 36382930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis.
    Yunfeng G; Weiyang H; Xueyang H; Yilong H; Xin G
    Medicine (Baltimore); 2017 Jul; 96(27):e7368. PubMed ID: 28682886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis.
    Haseen F; Murray LJ; Cardwell CR; O'Sullivan JM; Cantwell MM
    J Cancer Surviv; 2010 Jun; 4(2):128-39. PubMed ID: 20091248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis.
    Bigaran A; Zopf E; Gardner J; La Gerche A; Murphy DG; Howden EJ; Baker MK; Cormie P
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):35-48. PubMed ID: 32860010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis.
    Shao W; Zhang H; Qi H; Zhang Y
    PLoS One; 2022; 17(2):e0263918. PubMed ID: 35167609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle interventions to alleviate side effects on prostate cancer patients receiving androgen deprivation therapy: a meta-analysis.
    Ying M; Zhao R; Jiang D; Gu S; Li M
    Jpn J Clin Oncol; 2018 Sep; 48(9):827-834. PubMed ID: 30053039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
    Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
    Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
    Joseph JS; Lam V; Patel MI
    Eur Urol Oncol; 2019 Sep; 2(5):551-561. PubMed ID: 31411986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial.
    Freedland SJ; Howard L; Allen J; Smith J; Stout J; Aronson W; Inman BA; Armstrong AJ; George D; Westman E; Lin PH
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):428-437. PubMed ID: 30664736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials.
    Teleni L; Chan RJ; Chan A; Isenring EA; Vela I; Inder WJ; McCarthy AL
    Endocr Relat Cancer; 2016 Feb; 23(2):101-12. PubMed ID: 26584972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review.
    Wilson RL; Taaffe DR; Newton RU; Hart NH; Lyons-Wall P; Galvão DA
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
    Owen PJ; Daly RM; Livingston PM; Fraser SF
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.
    Bosco C; Crawley D; Adolfsson J; Rudman S; Van Hemelrijck M
    PLoS One; 2015; 10(3):e0117344. PubMed ID: 25794005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Exercise on Improving Body Composition and PSA in High-Risk Prostate Cancer Patients on Androgen-Deprivation Therapy.
    Lin YC; Shao IH; Juan YH; Yeh KY; Hou CP; Chen CL; Yu KJ; Chen LS; Lin CL; Chuang HH
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.